The Role of Hepatic Macrophages in Nonalcoholic Fatty Liver Disease and Nonalcoholic Steatohepatitis

Overview

Journal Lab Anim Res

Date 2019 Jan 24

PMID 30671098

Citations 39

Authors

Ji-Young Cha

Da-Hyun Kim

Kyung-Hee Chun

Affiliations

Soon will be listed here.

Abstract

Nonalcoholic steatohepatitis (NASH) is becoming common chronic liver disease because of the increasing global prevalence of obesity and consequently Nonalcoholic fatty liver disease (NAFLD). However, the mechanism for progression of NAFLD to NASH and then cirrhosis is not completely understood, yet. The triggering of these hepatic diseases is thought from hepatocyte injury caused by over-accumulated lipid toxicity. Injured hepatocytes release damage-associated molecular patterns (DAMPs), which can stimulate the Kupffer cells (KCs), liver-resident macrophages, to release pro-inflammatory cytokines and chemokines, and recruit monocyte-derived macrophages (MDMs). The increased activation of KCs and recruitment of MDMs accelerate the progression of NAFLD to NASH and cirrhosis. Therefore, characterization for activation of hepatic macrophages, both KCs and MDMs, is a baseline to figure out the progression of hepatic diseases. The purpose of this review is to discuss the current understanding of mechanisms of NAFLD and NASH, mainly focusing on characterization and function of hepatic macrophages and suggests the regulators of hepatic macrophages as the therapeutic target in hepatic diseases.

Citing Articles

Metabolic Reprograming of Macrophages: A New Direction in Traditional Chinese Medicine for Treating Liver Failure.

Zhang J, Li N, Hu X J Immunol Res. 2025; 2024():5891381.

PMID: 39741958 PMC: 11688140. DOI: 10.1155/jimr/5891381.

MIST1 regulates endoplasmic reticulum stress-induced hepatic apoptosis as a candidate marker of fatty liver disease progression.

Hur S, Jeong H, Kim K, Kim K, Kim S, Lee Y Cell Death Dis. 2024; 15(11):805.

PMID: 39516480 PMC: 11549289. DOI: 10.1038/s41419-024-07217-0.

Novel Peripherally Selective Cannabinoid Receptor 1 Neutral Antagonist Improves Metabolic Dysfunction-Associated Steatotic Liver Disease in Mice.

Laudermilk L, Schlosburg J, Gay E, Decker A, Williams A, Runton R ACS Pharmacol Transl Sci. 2024; 7(9):2856-2868.

PMID: 39296275 PMC: 11406686. DOI: 10.1021/acsptsci.4c00356.

Proanthocyanidins-Based Synbiotics as a Novel Strategy for Nonalcoholic Fatty Liver Disease (NAFLD) Risk Reduction.

Thilakarathna W, Rupasinghe H Molecules. 2024; 29(3).

PMID: 38338453 PMC: 10856248. DOI: 10.3390/molecules29030709.

Isolated from Raw Milk Improves Liver Function, Hepatic Steatosis, and Lipid Metabolism in Non-Alcoholic Fatty Liver Disease Mouse Model.

Kim H, Lee K, Kim J, Shim J, Lim J, Kim J Microorganisms. 2023; 11(10).

PMID: 37894124 PMC: 10609090. DOI: 10.3390/microorganisms11102466.

References

Fujimoto M, Uemura M, Nakatani Y, Tsujita S, Hoppo K, Tamagawa T . Plasma endotoxin and serum cytokine levels in patients with alcoholic hepatitis: relation to severity of liver disturbance. Alcohol Clin Exp Res. 2000; 24(4 Suppl):48S-54S. View

Duffield J, Forbes S, Constandinou C, Clay S, Partolina M, Vuthoori S . Selective depletion of macrophages reveals distinct, opposing roles during liver injury and repair. J Clin Invest. 2005; 115(1):56-65. PMC: 539199. DOI: 10.1172/JCI22675. View

Tacke F, Randolph G . Migratory fate and differentiation of blood monocyte subsets. Immunobiology. 2006; 211(6-8):609-18. DOI: 10.1016/j.imbio.2006.05.025. View

Mari M, Caballero F, Colell A, Morales A, Caballeria J, Fernandez A . Mitochondrial free cholesterol loading sensitizes to TNF- and Fas-mediated steatohepatitis. Cell Metab. 2006; 4(3):185-98. DOI: 10.1016/j.cmet.2006.07.006. View

Thomas P, Lazure D, Moussa R, Bajenova O, Burke P, Ganguly A . Identification of two novel LPS-binding proteins in Kupffer cells: implications in TNF-alpha production. J Endotoxin Res. 2007; 12(6):352-7. DOI: 10.1179/096805106X118898. View

Rivera C, Adegboyega P, van Rooijen N, Tagalicud A, Allman M, Wallace M . Toll-like receptor-4 signaling and Kupffer cells play pivotal roles in the pathogenesis of non-alcoholic steatohepatitis. J Hepatol. 2007; 47(4):571-9. PMC: 2094119. DOI: 10.1016/j.jhep.2007.04.019. View

You Q, Cheng L, Kedl R, Ju C . Mechanism of T cell tolerance induction by murine hepatic Kupffer cells. Hepatology. 2008; 48(3):978-90. PMC: 2600585. DOI: 10.1002/hep.22395. View

Karlmark K, Weiskirchen R, Zimmermann H, Gassler N, Ginhoux F, Weber C . Hepatic recruitment of the inflammatory Gr1+ monocyte subset upon liver injury promotes hepatic fibrosis. Hepatology. 2009; 50(1):261-74. DOI: 10.1002/hep.22950. View

Breous E, Somanathan S, Vandenberghe L, Wilson J . Hepatic regulatory T cells and Kupffer cells are crucial mediators of systemic T cell tolerance to antigens targeting murine liver. Hepatology. 2009; 50(2):612-21. PMC: 4380144. DOI: 10.1002/hep.23043. View

10.

Ingersoll M, Spanbroek R, Lottaz C, Gautier E, Frankenberger M, Hoffmann R . Comparison of gene expression profiles between human and mouse monocyte subsets. Blood. 2009; 115(3):e10-9. PMC: 2810986. DOI: 10.1182/blood-2009-07-235028. View

11.

Bieghs V, Wouters K, van Gorp P, Gijbels M, de Winther M, Binder C . Role of scavenger receptor A and CD36 in diet-induced nonalcoholic steatohepatitis in hyperlipidemic mice. Gastroenterology. 2010; 138(7):2477-86, 2486.e1-3. PMC: 3114629. DOI: 10.1053/j.gastro.2010.02.051. View

12.

Harte A, da Silva N, Creely S, McGee K, Billyard T, Youssef-Elabd E . Elevated endotoxin levels in non-alcoholic fatty liver disease. J Inflamm (Lond). 2010; 7:15. PMC: 2873499. DOI: 10.1186/1476-9255-7-15. View

13.

Lang P, Recher M, Honke N, Scheu S, Borkens S, Gailus N . Tissue macrophages suppress viral replication and prevent severe immunopathology in an interferon-I-dependent manner in mice. Hepatology. 2010; 52(1):25-32. DOI: 10.1002/hep.23640. View

14.

Thomson A, Knolle P . Antigen-presenting cell function in the tolerogenic liver environment. Nat Rev Immunol. 2010; 10(11):753-66. DOI: 10.1038/nri2858. View

15.

Lopez B, Tsai M, Baratta J, Longmuir K, Robertson R . Characterization of Kupffer cells in livers of developing mice. Comp Hepatol. 2011; 10(1):2. PMC: 3148529. DOI: 10.1186/1476-5926-10-2. View

16.

Murray P, Wynn T . Protective and pathogenic functions of macrophage subsets. Nat Rev Immunol. 2011; 11(11):723-37. PMC: 3422549. DOI: 10.1038/nri3073. View

17.

Bieghs V, van Gorp P, Walenbergh S, Gijbels M, Verheyen F, Buurman W . Specific immunization strategies against oxidized low-density lipoprotein: a novel way to reduce nonalcoholic steatohepatitis in mice. Hepatology. 2012; 56(3):894-903. PMC: 3374908. DOI: 10.1002/hep.25660. View

18.

Antoniades C, Quaglia A, Taams L, Mitry R, Hussain M, Abeles R . Source and characterization of hepatic macrophages in acetaminophen-induced acute liver failure in humans. Hepatology. 2012; 56(2):735-46. DOI: 10.1002/hep.25657. View

19.

Farrell G, Van Rooyen D, Gan L, Chitturi S . NASH is an Inflammatory Disorder: Pathogenic, Prognostic and Therapeutic Implications. Gut Liver. 2012; 6(2):149-71. PMC: 3343154. DOI: 10.5009/gnl.2012.6.2.149. View

20.

Liaskou E, Zimmermann H, Li K, Oo Y, Suresh S, Stamataki Z . Monocyte subsets in human liver disease show distinct phenotypic and functional characteristics. Hepatology. 2012; 57(1):385-98. PMC: 4194426. DOI: 10.1002/hep.26016. View